23
Jul
2019

CRISPR Boosts Animal Models, Making Preclinical Research More Efficient

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $149 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

Biopharma Gets Serious, In a Hurry, About Virtual Clinical Trials
Beyond CAR-T: New Engineered Immune Cell Types Head to the Clinic
Cancer Drugmakers Seek to Broaden Use of Tissue-Agnostic Therapies
Solid Tumors Have Eluded CAR-T, But Novel Targets and Techniques Are At Hand